Your Location:
Home >
Browse articles >
Shexiang Tongxin Dropping Pill (麝香通心滴丸) Reduces Coronary Microembolization in Rats via Regulation of Mitochondrial Permeability Transition Pore Opening and AKT-GSK3β Phosphorylation
Original Article | Updated:2021-09-01
    • Shexiang Tongxin Dropping Pill (麝香通心滴丸) Reduces Coronary Microembolization in Rats via Regulation of Mitochondrial Permeability Transition Pore Opening and AKT-GSK3β Phosphorylation

    • Shexiang Tongxin Dropping Pill (麝香通心滴丸) Reduces Coronary Microembolization in Rats via Regulation of Mitochondrial Permeability Transition Pore Opening and AKT-GSK3β Phosphorylation

    • Chinese Journal of Integrative Medicine   2021年27卷第7期 页码:527-533
    • DOI:10.1007/s11655-019-3176-6    

      中图分类号:
    • 纸质出版日期:2021-07-01

      网络出版日期:2020-01-04

      录用日期:2019-03-20

    Scan for full text

  • Yu DING, Hou-yong ZHU, Li-zong ZHANG, 等. Shexiang Tongxin Dropping Pill (麝香通心滴丸) Reduces Coronary Microembolization in Rats via Regulation of Mitochondrial Permeability Transition Pore Opening and AKT-GSK3β Phosphorylation[J]. Chinese Journal of Integrative Medicine, 2021,27(7):527-533. DOI: 10.1007/s11655-019-3176-6.

    Yu DING, Hou-yong ZHU, Li-zong ZHANG, et al. Shexiang Tongxin Dropping Pill (麝香通心滴丸) Reduces Coronary Microembolization in Rats via Regulation of Mitochondrial Permeability Transition Pore Opening and AKT-GSK3β Phosphorylation[J]. Chinese Journal of Integrative Medicine, 2021,27(7):527-533. DOI: 10.1007/s11655-019-3176-6.

  •  
  •  
More>

0

浏览量

0

Downloads

2

CSCD

文章被引用时,请邮件提醒。
Submit
工具集
下载
参考文献导出
分享
收藏
添加至我的专辑

相关文章

Shexiang Tongxin Dropping Pill (麝香通心滴丸) Protects against Na2S2O4-Induced Hypoxia-Reoxygenation Injury in H9c2 Cells
Chemical Composition, Pharmacological Effects and Clinical Applications of Cinobufacini
Immunomodulatory Function of Pien Tze Huang in T Cell-Mediated Anti-tumor Activity against B16-F10, MC38 and Hep1-6 Tumor Models
Safflower Yellow Inhibits Progression of Hepatocellular Carcinoma by Modulating Immunological Tolerance via FAK Pathway
Immunoregulatory and Anti-cancer Activities of Combination Treatment of Novel Four-Herb Formula and Doxorubicin in 4T1-Breast Cancer Bearing Mice

相关作者

暂无数据

相关机构

Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine
Fujian Key Laboratory of Integrative Medicine on Geriatric, Fujian University of Traditional Chinese Medicine
Rainbow Babies Children's Hospital, Case Western Reserve University School of Medicine
Inner Mongolia Conba Pharmaceutical Co., Ltd.
Chen Ke-ji Academic Thought Heritage Studio
0